References
- Ziegler JW, Todres ID. Intubation of newborns. Am J Dis Child. 1992;146(2):147–149.
- Sarkar S, Schumacher RE, Baumgart S, et al. Are newborns receiving premedication before elective intubation? J Perinatol. 2006;26(5):286–289.
- Welzing L, Kribs A, Eifinger F, et al. Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Paediatr Anaesth. 2010;20(7):605–611.
- Dekker J, Lopriore E, van Zanten HA, et al. Sedation during minimal invasive surfactant therapy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2019;104(4):F378–F383.
- De Luca D, Shankar-Aguilera S, Centorrino R, et al. Less invasive surfactant administration: a word of caution. Lancet Child Adolesc Health. 2020;4(4):331–340.
- Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome – 2019 update. Neonatology. 2019;115(4):432–450.
- Klotz D, Porcaro U, Fleck T, et al. European perspective on less invasive surfactant administration-a survey. Eur J Pediatr. 2017;176(2):147–154.
- Szczapa T, Hożejowski R, Krajewski P, Study Group. Implementation of less invasive surfactant administration in clinical practice-Experience of a mid-sized country. PLOS One. 2020;15(7):e0235363.
- Kurepa D, Perveen S, Lipener Y, et al. The use of less invasive surfactant administration (LISA) in the United States with review of the literature. J Perinatol. 2019;39(3):426–432.
- Bhayat S, Kaur A, Premadeva I, et al. Survey of less invasive surfactant administration in England, slow adoption and variable practice. Acta Paediatr. 2020;109(3):505–510.
- Fernandez C, Boix H, Camba F, et al. Less invasive surfactant administration in Spain: a survey regarding its practice, the target population, and premedication use. Am J Perinatol. 2020;37(3):277–280.
- Heiring C, Jonsson B, Andersson S, et al. Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration. Acta Paediatr. 2017;106(3):382–386.
- Descamps CS, Chevallier M, Ego A, et al. Propofol for sedation during less invasive surfactant administration in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2017;102(5):F465.
- Dolansky G, Shah A, Mosdossy G, et al. What is the evidence for the safety and efficacy of using ketamine in children? Paediatr Child Health. 2008;13(4):307–308.
- Mistry RB, Nahata MC. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy. 2005;25(8):1104–1111.
- Green SM, Johnson NE. Ketamine sedation for pediatric procedures: part 2, review and implications. Ann Emerg Med. 1990;19(9):1033–1046.
- Wu C, Wang J, Guo X, et al. Ketamine exacerbates cortical neuroapoptosis under hyperoxic conditions by upregulating expression of the N-methyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC Anesthesiol. 2018;18(1):52.
- Green SM, Roback MG, Kennedy RM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–461.
- Bucher HU, Moser T, von Siebenthal K, et al. Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr Res. 1995;38(3):332–335.
- Abad F, Diaz NM, Domenech E, et al. Oral sweet solution reduces pain-related behaviour in preterm infants. Acta Paediatr. 1996;85(7):854–858.
- Ramenghi LA, Wood CM, Griffith GC, et al. Reduction of pain response in premature infants using intraoral sucrose. Arch Dis Child Fetal Neonatal Ed. 1996;74(2):F126–F128.
- Johnston CC, Stremler RL, Stevens BJ, et al. Effectiveness of oral sucrose and simulated rocking on pain response in preterm neonates. Pain. 1997;72(1–2):193–199.
- Lowrie L, Weiss AH, Lacombe C. The pediatric sedation unit: a mechanism for pediatric sedation. Pediatrics. 1998;102(3):E30–e30.